Elvucitabine Completed Phase 2 Trials for Human Immunodeficiency Virus (HIV) Infections Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
https://clinicaltrials.gov/ct2/show/Elvucitabine/Efavirenz/Tenofovir vs. Lamivudine/Efavirenz/Tenofovir in HIV-1 Infected, Treatment Naive Subjects
https://clinicaltrials.gov/ct2/show/Safety Study of Elvucitabine in HIV-1 Subjects
https://clinicaltrials.gov/ct2/show/An Open Label Treatment Protocol to Provide Continued Elvucitabine Treatment